Oncology/Hematology

Chemotherapy

Latest AI and machine learning research in chemotherapy for healthcare professionals.

4,338 articles
Stay Ahead - Weekly Chemotherapy research updates
Subscribe
Browse Categories
Showing 1541-1560 of 4,338 articles

A Machine Learning Model Optimized for Local Data Stratifies Patients for the Adoptive Cell Therapy with Tumor Infiltrating Lymphocytes in Bladder Tumors

Adoptive cell therapy with tumor-infiltrating lymphocytes (ACT-TILs) involves autologous TILs that are expanded ex vivo and then reinfused into the patient as a personalized form of therapy. For bladder cancer patients, there is a unique opportunity to deliver TILs locally, through intravesical administration, without systemic cytotoxic chemotherapy to induce lymphodepletion. Improved selection of...

Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised Transformer

Recurrence related to poor prognosis is a leading cause of mortality in patients with breast cancer (BC). The MammaPrint (MP) genomic assay is designed to stratify recurrence risk and evaluate chemotherapy benefits for early-stage HR+/HER2- BC patients. However, MP fails to reveal spatial tumor morphology and is limited by high costs. In this study, we establish a BC MP cohort and develop CPMP, a ...

Identifying tissue states by spatial protein patterns related to chemotherapy response in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive malignancy with limited targeted therapies and variable responses to conventional chemotherapy, ...

Single-cell RNA sequencing and large-scale bulk combination with machine learning reveal gastric cancer-related macrophage heterogeneity

The tumor microenvironment (TME) significantly impacts cancer progression and overall patient survival. However, the complexity of tumor cell-TME inte...

Deep Learning Bridges Histology and Transcriptomics to Predict Molecular Subtypes and Outcomes in Muscle-Invasive Bladder Cancer

Muscle-Invasive Bladder Cancer (MIBC) is a heterogeneous disease with distinct molecular subtypes influencing prognosis and therapeutic response. Howe...

Single recipient cell tracking of tellurium-labeled extracellular vesicle proteomes (TeLEV) identifies EV-driven immunomodulation

Extracellular vesicles (EVs) mediate tumor-immune cell communication by carrying protein cargo that can immediately modulate signaling and antigen pre...

Deep learning inference of universal dormancy pseudotime reveals the cellular targets of anti-cancer therapies

Controlled exit from and re-entry into the cell cycle is essential for multi-cellular life, while aberrant quiescent and senescent cell states have be...

High throughput quantitative tracking of single parasite in Plasmodium falciparum

New systematic profiling of drug effects is in urgent demand due to limitations in existing drug assessment approaches to evaluate comprehensive drug ...

Spatially distinct chromatin compaction states predict neoadjuvant chemotherapy resistance in Triple Negative Breast Cancer

Organisation and dynamics of chromatin play a key role in regulation of cell state and function. In cancer, chromatin plasticity is known to be import...

A Druggable Tumor Suppressor and Leukemic Stem Cell Marker

Acute myeloid leukemia (AML) often enters remission after chemotherapy but frequently relapses due to chemotherapy-resistant leukemic stem cells (LSCs...

VaxjoGNN: A Graph Neural Network for Ontology-Grounded Vaccine Adjuvant Recommendation

The selection of an effective adjuvant is a critical bottleneck in vaccine development, particularly for emerging diseases where experimental data is ...

A Lung CT Foundation Model Facilitating Disease Diagnosis and Medical Imaging

The concomitant development and evolution of lung computed tomography (CT) and artificial intelligence (AI) has allowed non-invasive lung imaging to b...

Establishment of in silico prediction of adjuvant chemotherapy response from active mitotic gene signature in non-small cell lung cancer

Conventional chemotherapeutics exploit cancer’s hallmark of active cell cycling, primarily targeting mitotic cells. Consequently, the mitotic index (M...

Tumor-infiltrating lymphocytes in breast cancer through artificial intelligence: biomarker analysis from the results of the TIGER challenge

The prognostic significance of tumor-infiltrating lymphocytes (TILs) in breast cancer has been recognized for over a decade. Although histology-based ...

Robust cancer crowdfunding predictions: Leveraging large language models and machine learning for success analysis

In the field of medical crowdfunding prediction, traditional statistical methods have long been the standard. Machine learning algorithms are popular ...

Unmet Needs in Acute Hepatic Porphyria Diagnosis: A Comparative Big Data Analysis of an AI-based Human-in-the-Loop Screening Versus Standard of Care

Acute Hepatic Porphyria (AHP) is a rare genetic disease characterized by unpredictable life-threatening attacks. There is no reliable biochemical scre...

Predicting agranulocytosis in patients treated with clozapine – development and validation of a machine learning algorithm based on 5,550 patients

To prevent clozapine-induced agranulocytosis (CIA), patients’ white blood cell counts are closely monitored, with treatment stopped if the absolute ne...

Conversational Artificial Intelligence for Translational Precision Medicine: Integrating Social Determinants of Health, Genomics, and Clinical Data with AI-HOPE-PM

Introduction: Achieving equity in translational precision medicine requires the integration of genomic, clinical, and social determinants of health (S...

Deep learning clarifies association of osteoporosis risk with bone metastasis in premenopausal women after surgery for early-stage breast cancer: a multicenter retrospective cohort study

Adjuvant use of bone-modifying agents (BMAs) to early-stage breast cancer (eBC) aims to maintain bone density, leading to prevention of bone metastasi...

Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit

Genomic testing has transformed treatment decisions for hormone receptor-positive, HER2-negative (HR+/HER2-) early breast cancer; however, it remains ...

Browse Categories